ARCATO LABORATORIES, INC.
Greensboro, NC · Biotech · Private
LBB-111, a proprietary resorbable emulsion of three anesthetic drugs for sustained post-operative dental pain relief
arcatolabs.com →- Grants
- $3.1M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20182019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Non-Opiate Topical Formulations for Treating Pain Associated with Molar Extractions | $145,566 | |
| Federal grant | Department of Health and Human Services · Phase II · Non-opiate topical formulations for treating pain associated with molar extractions | $2,257,823 | |
| Federal grant | Department of Health and Human Services · Phase II · Non-opiate topical formulations for treating pain associated with molar extractions | $715,640 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1977 | CILA THERAPEUTIC INC. | — | — |
| 1978 | Liberation Technology Services, Inc. | — | $25K |
| 1979 | GORDIAN BIOTECHNOLOGY, INC. | — | — |
| 1980 | ARCATO LABORATORIES, INC. | — | — |
| 1981 | Corxel | — | — |
| 1982 | CytomX Therapeutics | — | $143M |
| 1983 | POP ART, INC. | — | $1.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.